BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev 2021:bnab019. [PMID: 34147030 DOI: 10.1210/endrev/bnab019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Fargette C, Shulkin B, Jha A, Pacak K, Taïeb D. Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. Front Oncol 2022;12:1081783. [PMID: 36733351 DOI: 10.3389/fonc.2022.1081783] [Reference Citation Analysis]
2 Pappachan JM, Fernandez CJ. Endocrine hypertension—an overview. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00022-4] [Reference Citation Analysis]
3 Valaiyapathi B, Ashraf AP. Endocrine hypertension in children. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00008-x] [Reference Citation Analysis]
4 Fernandez CJ, Hanna FW, Pacak K, Nazari MA. Catecholamines and blood pressure regulation. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00010-8] [Reference Citation Analysis]
5 Goemann IM, Maia AL. Pheochromocytomas and hypertension. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00003-0] [Reference Citation Analysis]
6 Zelinka T, Petrák O. Paragangliomas and hypertension. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00007-8] [Reference Citation Analysis]
7 Juhlin CC, Mete O. Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists. Adv Anat Pathol 2023;30:47-57. [PMID: 36136370 DOI: 10.1097/PAP.0000000000000365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cunningham E, Kennedy A, Gregg S, O'Halloran DJ, Lowney A. Palliative Symptom Management in Malignant Pheochromocytoma: Safe Use of Fentanyl and a Review of Medications Used. J Palliat Med 2022. [PMID: 36580562 DOI: 10.1089/jpm.2022.0402] [Reference Citation Analysis]
9 Marcus C, Subramaniam RM. Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy. PET Clin 2022:S1556-8598(22)00093-1. [PMID: 36585340 DOI: 10.1016/j.cpet.2022.11.006] [Reference Citation Analysis]
10 Wang Y, Liu L, Chen D, Pang Y, Xu X, Liu J, Li M, Guan X. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas. J Endocrinol Invest 2022. [DOI: 10.1007/s40618-022-01984-3] [Reference Citation Analysis]
11 Pacak K. New Biology of Pheochromocytoma and Paraganglioma. Endocr Pract 2022;28:1253-69. [PMID: 36150627 DOI: 10.1016/j.eprac.2022.09.003] [Reference Citation Analysis]
12 Tang SS, Lee JWK, Wijerethne S, Iyer SG, Hue S, En NM, Parameswaran R. Locally invasive recurrence or metastasis of pheochromocytoma into the liver?—clinicopathological challenges. World J Surg Onc 2022;20:360. [DOI: 10.1186/s12957-022-02817-6] [Reference Citation Analysis]
13 Hadrava vanova K, Uher O, Meuter L, Ghosal S, Talvacchio S, Patel M, Neuzil J, Pacak K. PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1045517] [Reference Citation Analysis]
14 Xue R, Hu C, Zheng Z, Wei L, Yuan X, Lyu X, Shen P, Li J, Cao X. Renal‑rotation techniques in retroperitoneoscopic adrenalectomy for giant pheochromocytomas: a clinical intervention study with historical controls.. [DOI: 10.21203/rs.3.rs-2202358/v1] [Reference Citation Analysis]
15 Araujo-Castro M, Redondo López S, Pascual-Corrales E, Polo López R, Alonso-Gordoa T, Molina-Cerrillo J, Moreno Mata N, Caballero Silva U, Barberá Durbán R. Surgical and non-surgical management of thoracic and cervical paraganglioma. Ann Endocrinol (Paris) 2022:S0003-4266(22)00857-5. [PMID: 36334803 DOI: 10.1016/j.ando.2022.10.013] [Reference Citation Analysis]
16 Schmidt S, Kloos C, Busch M, Wolf G. Sinnvolle Diagnose und Therapie von hormonabhängigen Hypertonusformen. Dialyse aktuell 2022;26:416-423. [DOI: 10.1055/a-1872-4206] [Reference Citation Analysis]
17 Maria Lider Burciulescu S, Livia Gheorghiu M. Advances in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas in the Era of Personalized Genetic Diagnostic. Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment [Working Title] 2022. [DOI: 10.5772/intechopen.108298] [Reference Citation Analysis]
18 Wang ZH, Fan JR, Zhang GY, Li XL, Li L. Atypical Takotsubo cardiomyopathy presenting as acute coronary syndrome: A case report. World J Clin Cases 2022; 10(29): 10772-10778 [DOI: 10.12998/wjcc.v10.i29.10772] [Reference Citation Analysis]
19 Ene CD, Nicolae I. Hypoxia-Nitric Oxide Axis and the Associated Damage Molecular Pattern in Cutaneous Melanoma. J Pers Med 2022;12. [PMID: 36294785 DOI: 10.3390/jpm12101646] [Reference Citation Analysis]
20 Brown KF, Dear JM, Shakir MKM, Hoang TD. Abdominal Pain, Progressive Weakness, and Weight Loss in an 83-Year-Old Man. AACE Clin Case Rep 2023;9:25-6. [PMID: 36654997 DOI: 10.1016/j.aace.2022.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gubbi S, Vijayvergia N, Yu JQ, Klubo-Gwiezdzinska J, Koch CA. Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors. Horm Metab Res 2022;54:795-812. [PMID: 35878617 DOI: 10.1055/a-1908-7790] [Reference Citation Analysis]
22 Feng Q, Li H, Qiu G, Cai Z, Li J, Zeng Y, Huang J. Case report: Significant liver atrophy due to giant cystic pheochromocytoma. Front Oncol 2022;12:987705. [DOI: 10.3389/fonc.2022.987705] [Reference Citation Analysis]
23 Kong W, Qu Q, Zhang S. Recurrent paraganglioma of the vulva: A rare case report and review of the literature. Front Oncol 2022;12:961666. [DOI: 10.3389/fonc.2022.961666] [Reference Citation Analysis]
24 Patel M, Jha A, Ling A, Chen CC, Millo C, Kuo MJM, Nazari MA, Talvacchio S, Charles K, Miettinen M, Del Rivero J, Chen AP, Nilubol N, Lin FI, Civelek AC, Taïeb D, Carrasquillo JA, Pacak K. Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A-Related Metastatic Pheochromocytoma and Paraganglioma. Cancers 2022;14:3886. [DOI: 10.3390/cancers14163886] [Reference Citation Analysis]
25 Nikas IP, Ishak A, Alrawashdeh MM, Klapsinou E, Sepsa A, Tzimas GN, Panagiotakopoulos D, Papaioannou D, Salla C. Preoperative Diagnosis of Abdominal Extra-Adrenal Paragangliomas with Fine-Needle Biopsy. Diagnostics 2022;12:1819. [DOI: 10.3390/diagnostics12081819] [Reference Citation Analysis]
26 Bima C, Bioletto F, Lopez C, Bollati M, Arata S, Procopio M, Gesmundo I, Ghigo E, Maccario M, Parasiliti-caprino M. Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma. Biomedicines 2022;10:1813. [DOI: 10.3390/biomedicines10081813] [Reference Citation Analysis]
27 Santos MS, Teixeira MM, Alves A, Pereira BD, Henriques M. A Case of Paraganglioma-Induced Adrenergic Shock. Cureus 2022. [DOI: 10.7759/cureus.26925] [Reference Citation Analysis]
28 Kuo MJM, Nazari MA, Jha A, Pacak K. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches. Front Endocrinol 2022;13:936178. [DOI: 10.3389/fendo.2022.936178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Refardt J, Hofland J, Wild D, Christ E. Molecular Imaging of Neuroendocrine Neoplasms. J Clin Endocrinol Metab 2022;107:e2662-70. [PMID: 35380158 DOI: 10.1210/clinem/dgac207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Parisien-La Salle S, Chbat J, Lacroix A, Perrotte P, Karakiewicz P, Saliba I, Le XK, Olney HJ, Bourdeau I. Postoperative Recurrences in Patients Operated for Pheochromocytomas and Paragangliomas: New Data Supporting Lifelong Surveillance. Cancers (Basel) 2022;14:2942. [PMID: 35740606 DOI: 10.3390/cancers14122942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Iravani A, Parihar AS, Akhurst T, Hicks RJ. Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms. Cancer Imaging 2022;22. [DOI: 10.1186/s40644-022-00465-3] [Reference Citation Analysis]
32 Werner RA, Schirbel A, Buck AK, Fassnacht M, Hahner S. Adrenal functional imaging. Presse Med 2022;51:104114. [PMID: 35131316 DOI: 10.1016/j.lpm.2022.104114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Talvacchio S, Nazari MA, Pacak K. Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment. Curr Opin Endocrinol Diabetes Obes 2022;29:294-301. [PMID: 35621181 DOI: 10.1097/MED.0000000000000724] [Reference Citation Analysis]
34 Remde H, Pamporaki C, Quinkler M, Nölting S, Prejbisz A, Timmers HJLM, Masjkur J, Fuss CT, Fassnacht M, Eisenhofer G, Deutschbein T. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine. Hypertension 2022;79:1257-64. [PMID: 35378989 DOI: 10.1161/HYPERTENSIONAHA.122.19019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Calissendorff J, Juhlin CC, Bancos I, Falhammar H. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. Cancers 2022;14:917. [DOI: 10.3390/cancers14040917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
36 Sarkadi B, Saskoi E, Butz H, Patocs A. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach. Int J Mol Sci 2022;23:1450. [PMID: 35163370 DOI: 10.3390/ijms23031450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chung R, O'Shea A, Sweeney AT, Mercaldo ND, McDermott S, Blake MA. Hereditary and Sporadic Pheochromocytoma: Comparison of Imaging, Clinical, and Laboratory Features. AJR Am J Roentgenol 2022. [PMID: 35080458 DOI: 10.2214/AJR.21.26918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Reincke M. [Adrenal diseases]. Internist (Berl) 2022;63:1-3. [PMID: 35029713 DOI: 10.1007/s00108-021-01239-y] [Reference Citation Analysis]
39 Takács-Vellai K, Farkas Z, Ősz F, Stewart GW. Model systems in SDHx-related pheochromocytoma/paraganglioma. Cancer Metastasis Rev 2021. [PMID: 34957538 DOI: 10.1007/s10555-021-10009-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Remde H, Nölting S. [Pheochromocytoma - Disease Model for Personalized Medicine]. Dtsch Med Wochenschr 2021;146:1520-6. [PMID: 34826837 DOI: 10.1055/a-1240-9835] [Reference Citation Analysis]
41 Winzeler B, Challis BG, Casey RT. Precision Medicine in Phaeochromocytoma and Paraganglioma. J Pers Med 2021;11:1239. [PMID: 34834591 DOI: 10.3390/jpm11111239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Gao Y, Ling C, Ma X, Wang H, Cui Y, Nie M, Tong A. Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas. Int J Endocrinol 2021;2021:1392386. [PMID: 34630562 DOI: 10.1155/2021/1392386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Wang K, Tang G, Peng Y, Li C, Fu W, Li R, Guan J. Adrenal pheochromocytoma: is it all or the tip of the iceberg? Jpn J Radiol 2021. [PMID: 34546504 DOI: 10.1007/s11604-021-01199-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Flores SK, Estrada-Zuniga CM, Thallapureddy K, Armaiz-Peña G, Dahia PLM. Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers. Cancers (Basel) 2021;13:4602. [PMID: 34572828 DOI: 10.3390/cancers13184602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
45 Arsovic E, Montava M, Fakhry N, Lavieille JP, Pacak K, Taïeb D, Varoquaux A. Quantitative biomarkers allow the diagnosis of head and neck paraganglioma on multiparametric MRI. Eur J Radiol 2021;143:109911. [PMID: 34508941 DOI: 10.1016/j.ejrad.2021.109911] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Abdel-Rahman O. Assessment of the AJCC staging system of pheochromocytomas/paragangliomas. Endocrine 2021. [PMID: 34449032 DOI: 10.1007/s12020-021-02854-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sarkadi B, Liko I, Nyiro G, Igaz P, Butz H, Patocs A. Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma. Cancers (Basel) 2021;13:4219. [PMID: 34439371 DOI: 10.3390/cancers13164219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]